Trial Profile
Evaluation of the effect of food on the pharmacokinetics of axitinib in healthy volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 27 Aug 2012
Price :
$35
*
At a glance
- Drugs Axitinib (Primary)
- Indications Breast cancer; Colorectal cancer; Gastrointestinal cancer; Non-small cell lung cancer; Renal cancer; Solid tumours; Thyroid cancer
- Focus Pharmacokinetics
- Sponsors Pfizer
- 05 Nov 2010 New trial record.